T1	Treatment 27 45	placebo-controlled
T2	Treatment 84 114	recombinant human antithrombin
T3	Treatment 268 305	recombinant human antithrombin (rhAT)
T4	Treatment 570 577	Heparin
T5	Treatment 671 679	heparin.
T6	Treatment 746 806	received 75 U/kg rhAT, and the other received normal saline.
T7	Treatment 1031 1035	rhAT
T8	Treatment 1109 1116	placebo
T9	Treatment 1189 1193	rhAT
T10	Treatment 1267 1274	placebo
T11	Treatment 1340 1347	heparin
T12	Treatment 1451 1456	rhAT.
T13	Treatment 1571 1575	rhAT
T14	Treatment 1707 1711	rhAT
T15	Treatment 1891 1895	rhAT
